Pathophysiological mechanisms of carotid plaque vulnerability: Impact on ischemic stroke

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 6, 2012, Pages 431-442

  Pelisek, Jaroslav ^a   Eckstein, Hans Henning ^a   Zernecke, Alma ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Carotid atherosclerosis; Ischemic stroke; Vulnerable carotid plaque

Indexed keywords

ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CELL DEGENERATION; CHRONIC KIDNEY DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIGENETICS; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MOLECULAR PATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; REVIEW;

ANIMALS; BRAIN ISCHEMIA; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; COMORBIDITY; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RISK FACTORS; RUPTURE, SPONTANEOUS; STROKE;

EID: 84872115243     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0192-z     Document Type: Review

References (130)

1. Alderman EL, Corley SD, Fisher LD, Chaitman BR, Faxon DP, Foster ED, Killip T, Sosa JA, Bourassa MG, CASS Participating Investigators and Staff (1993) Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol 22:1141-1154
2. Apte SS (2004) A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 36:981-985
3. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512-523
4. Avogaro P, Bon GB, Cazzolato G (1988) Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8:79-87
5. Bayarsaihan D (2011) Epigenetic mechanisms in inflammation. J Dent Res 90:9-17
6. Blobel CP (2005) ADAMs: key components in EGFR signalling and development. Nature 6:32-43
7. Boumber Y, Issa JP (2011) Epigenetics in cancer: what's the future? Oncology 25(220-6):228
8. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R (1997) Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336: 1276-1282
9. Caffarelli E, Filetici P (2011) Epigenetic regulation in cancer development. Front Biosci 17:2682-2694
10. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653-660
11. Castillo-Díaz SA, Garay-Sevilla ME, Hernández- González MA, Solís-Martínez MO, Zaina S (2010) Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries. Int J Mol Med 26:691-700
12. Chen CH, Walterscheid JP (2006) Plaque angiogenesis versus compensatory arteriogenesis in atherosclerosis. Circ Res 99:787-789
13. Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY (2003) Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 107:2102-2108
14. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT (1993) Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 87:1179-1187
15. Clarke M, Bennett M (2006a) Defining the role of vascular smooth muscle cell apoptosis in atherosclerosis. Cell Cycle 5:2329-2331
16. Clarke M, Bennett M (2006b) The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 26:531-535
17. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L (2003) VEGFreceptor signal transduction. Trends Biochem Sci 28:488-494
18. Di Stefano R, Felice F, Balbarini A (2009) Angiogenesis as risk factor for plaque vulnerability. Curr Pharm 15:1095-1106
19. Dollery CM, Libby P (2006) Atherosclerosis and proteinase activation. Cardiovasc Res 69:625-635
20. Dong C, Yoon W, Goldschmidt-Clermont PJ (2002) DNA methylation and atherosclerosis. J Nutr 132:2406S-2409S
21. Duffy MJ, McKiernan E, O'Donovan N, McGowan PM (2009) The role of ADAMs in disease pathophysiology. Clin Chim Acta 403:31-36
22. Eckstein HH (2012) Evidence-based management of carotid stenosis: recommendations from international guidelines. J Cardiovasc Surg (Torino) 53:3-13
23. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463
24. Fabjan JS, Abuja PM, Schaur RJ, Sevanian A (2001) Hypochlorite induces the formation of LDL(-), a potentially atherogenic low density lipoprotein subspecies. FEBS Lett 499:69-72
25. Ferrara N (2009) Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 29:779-789
26. Ferri N, Paoletti R, Corsini A (2006) Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation. Curr Opin Lipidol 17:495-501
27. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119
28. Formato M, Farina M, Spirito R, Maggioni M, Guarino A, Cherchi GM, Biglioli P, Edelstein C, Scanu AM (2004) Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries. Arterioscler Thromb Vasc Biol 24:129-135
29. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503
30. Galis ZS, Sukhova GK, Libby P (1995) Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 9:974- 980
31. Garcia-Touchard A, Henry TD, Sangiorgi G, Spagnoli LG, Mauriello A, Conover C, Schwartz RS (2005) Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 25:1119-1127
32. Ginsberg HN, Huang LS (2000) The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 7:325-331
33. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D et al (2000) Coronary-artery calcification in young adults with endstage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
34. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC (1996) Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 93:9748-9753
35. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, Aukrust P (2008) Atherosclerotic plaque stability - what determines the fate of a plaque? Prog Cardiovasc Dis 51:183-194
36. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
37. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204-212
38. Heider P, Pelisek J, Poppert H, Eckstein HH (2009) Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vasc Endovascular Surg 43:551-560
39. Heilmann C, Beyersdorf F, Lutter G (2002) Collateral growth: cells arrive at the construction site. Cardiovasc Surg 10:570-578
40. Herceg Z, Vaissière T (2011) Epigenetic mechanisms and cancer: an interface between the environment and the genome. Epigenetics 6:804-819
41. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT (2001) The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 103:1051-1056
42. Ingrosso D, Perna AF (2009) Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta 1790:892-899
43. Jones GC, Riley GP (2005) ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther 7:160-169
44. Karamysheva AF (2008) Mechanisms of angiogenesis. Biochemistry (Mosc) 73:751-762
45. Kim J, Kim JY, Song KS, Lee YH, Seo JS, Jelinek J, Goldschmidt-Clermont PJ, Issa JP (2007) Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in vitro vascular senescence. Biochim Biophys Acta 1772:72-80
46. Kinsella MG, Bressler SL, Wight TN (2004) The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14:203-234
47. Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, Andoh D, Toya Y, Yasuda G, Umemura S (2009) Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 24:201-207
48. Kunz J (2007) Matrix metalloproteinases and atherogenesis in dependence of age. Gerontology 53:63-73
49. Labat-Robert J, Bihari-Varga M, Robert L (1990) Extracellular matrix. FEBS Lett 268:386-393
50. Lahtz C, Pfeifer GP (2011) Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol 3:51-58
51. Langheinrich AC, Kampschulte M, Buch T, Bohle RM (2007) Vasa vasorum and atherosclerosis - Quid novi? Thromb Haemost 97:873-879
52. Lemaitre V, D'Armiento J (2006) Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 78:1-10
53. Leskinen Y, Lehtimaki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H, Salenius JP, Saha H (2003) Carotid atherosclerosis in chronic renal failure - the central role of increased plaque burden. Atherosclerosis 171:295-302
54. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
55. Libby P, Ridker PM, Hansson GK (2002) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317-325
56. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129-2138
57. Lim HS, Lip GY, Blann AD (2005) Angiopoietin-1 and angiopoietin- 2 in diabetes mellitus: relationship to VEGF glycaemic control endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 80:113-118
58. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM (2000) Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40-47
59. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827-1835
60. Lu J, Yang JH, Burns AR, ChenHH, Tang D,Walterscheid JP, Suzuki S, Yang CY, Sawamura T, Chen CH (2009)Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res 104:619-627
61. Lund G, Zaina S (2011) Atherosclerosis: an epigenetic balancing act that goes wrong. Curr Atheroscler Rep 13:208-214
62. Manthey HD, Zernecke A (2011) Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb Haemost 106:772-778
63. Mello AP, da Silva IT, Abdalla DS, Damasceno NR (2011) Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 215:257-265
64. Millichip MI, Dallas DJ, Wu E, Dale S, McKie N (1998) The metallodisintegrinADAM10 from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 245:594-598
65. Mochizuki S, Okada Y (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621-628
66. Montecucco F, Lenglet S, Gayet-Ageron A, Bertolotto M, Pelli G, Palombo D, Pane B, Spinella G, Steffens S, Raffaghello L, Pistoia V, Ottonello L, Pende A, Dallegri F, Mach F (2010) Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 41:1394-1404
67. Montecucco F, Di Marzo V, da Silva RF, Vuilleumier N, Capettini L, Lenglet S, Pagano S, Piscitelli F, Quintao S, Bertolotto M, Pelli G, Galan K, Pilet L, Kuzmanovic K, Burger F, Pane B, Spinella G, Braunersreuther V, Gayet-Ageron A, Pende A, Viviani GL, Palombo D, Dallegri F, Roux-Lombard P, Santos RA, Stergiopulos N, Steffens S, Mach F (2012) The activation of the cannabinoid receptor type 2 reduces neutrophilic proteasemediated vulnerability in atherosclerotic plaques. Eur Heart J 33:846-856
68. Mughal MM, Khan MK, DeMarco JK, Majid A, Shamoun F, Abela GS (2011) Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 9:1315-1330
69. Mukherjee D, Patil CG (2011) Epidemiology and the global burden of stroke. World Neurosurg 76:S85-S90
70. Muller JE, Tofler GH (1992) Triggering and hourly variation of onset of arterial thrombosis. Ann Epidemiol 2:393-405
71. Murata K, Motayama T, Kotake C (1986) Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis 60:251-262
72. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani-Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT (2003a) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108:21664-21672
73. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT (2003b) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108:1772-1778
74. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE (2002) Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106:2894-2900
75. Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85:1-31
76. Newby AC, Southgate KM, Davies M (1994) Extracellular matrix degrading metallo-proteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol 89:59-70
77. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW (1995) Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92:1393-1398
78. Ordovás JM, Smith CE (2010) Epigenetics and cardiovascular disease. Nat Rev Cardiol 7:510-519
79. Pelisek J, Shimizu M, Nikol S (2004) Differential developmental origin of arteries: impact on angiogenesis and arteriogenesis. Med Chem Rev 1:317-326
80. Pelisek J, Rudelius M, Zepper P, Poppert H, Reeps C, Schuster T, Eckstein HH (2009) Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis 28:601-610
81. Pelisek J, Assadian A, Sarkar O, Eckstein HH, Frank H (2010) Carotid plaque composition in chronic kidney disease: a retrospective analysis of patients undergoing carotid endarterectomy. Eur J Vasc Endovasc Surg 39:11-16
82. Pelisek J, Hahntow IN, Eckstein HH, Ockert S, Reeps C, Heider P, Luppa PB, Frank H (2011) Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg 54:1643-1649
83. Pelisek J, Reeps C, Ockert S, Zimmermann A, Zepper P, Poppert H, Eckstein HH (2012) Evaluation of serum biomarkers for patients at increased risk of stroke. Int J Vasc Med [Ahead of print]
84. Pelisek J, Well G, Reeps C, Rudelius M, Kuehnl A, Culmes M, Poppert H, Zimmermann A, Berger H, Eckstein HH (2012) Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J [Epub, ahead of print]
85. Perco P, Pleban C, Kainz A, Lukas A, Mayer B, Oberbauer R (2006) Protein biomarkers associated with acute renal failure and chronic kidney disease. Eur J Clin Invest 36:753-763
86. Plutzky J (2003) The vascular biology of atherosclerosis. Am J Med 115:55S-61S
87. Porter S, Clark IM, Kevorkian L, Edwards DR (2005) The ADAMTS metalloproteinases. Biochem J 386:15-27
88. Pries AR, Kuebler WM (2006) Normal endothelium. Handb Exp Pharmacol 176:1-40
89. Radford EJ, Ferrón SR, Ferguson-Smith AC (2011) Genomic imprinting as an adaptative model of developmental plasticity. FEBS Lett 585:2059-2066
90. Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ (2000) Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101:850-855
91. Redgrave JN, Gallagher PJ, Lovett JK, Rothwell PM (2008) Critical cap thickness and rupture in symptomatic carotid plaques: the Oxford Plaque Study. Stroke 39:1722-1729
92. Reeps C, Pelisek J, Seidl S, Schuster T, Zimmermann A, Kuehnl A, Eckstein HH (2009) Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology 76:243-252
93. Rey FE, Pagano PJ (2002) The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22:1962-1971
94. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
95. Rossi A, Bonfante L, Giacomini A, Calabro A, Rossi G, Saller A, Abbruzzese E, Baldo G, Mastrosimone S, Beccari A, Baiocchi MR, de Silvestro L, Roncali D, Bolzonella R, Giardin C, Antonello A, Normanno M, Crepaldi G, Borsatti A (1996) Carotid artery lesions in patients with nondiabetic chronic renal failure. Am J Kidney Dis 27:58-66
96. Rothwell PM (2000) Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis 10:21-33
97. Roy R, Zhang B, Moses MA (2006) Making the cut: proteasemediated regulation of angiogenesis. Exp Cell Res 312:608-622
98. Russo D, Morrone LF, Brancaccio S, Napolitano P, Salvatore E, Spadola R, Imbriaco M, Russo CV, Andreucci VE (2009) Pulse pressure and presence of coronary artery calcification. Clin J Am Soc Nephrol 4:316-322
99. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP (2004) Dictinct roles for ADAM 10 and ADAM 17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769-779
100. Savage T, Clarke AL, Giles M, Tomson CR, Raine AE (1998) Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 13:2004-2012
101. Schaper W, Scholz D (2003) Factors regulating arteriogenesis. Arterios Thromb Vasc Biol 23:1143-1151
102. Schmermund A, Erbel R (2001) Unstable coronary plaque and its relation to coronary calcium. Circulation 104:1682-1687
103. Schmidt AM, Stern D (2000) Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 2:430-436
104. Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteaes: multidomain proteins with multiple functions. Genes Dev 17:7-30
105. Serman A, Vlahović M, Serman L, Bulić-Jakus F (2006) DNA methylation as a regulatory mechanism for gene expression in mammals. Coll Antropol 30:665-671
106. Shen CM, Mao SJ, Huang GS, Yang PC, Chu RM (2001) Stimulation of smooth muscle cell proliferation by ox-LDL- and acetyl LDLinduced macrophage-derived foam cells. Life Sci 70:443-452
107. Shibuya M (2008) Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep 41:278-286
108. Shimizu M, Pelisek J, Nikol S (2002) Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree. Curr Med Chem 9:1619-1630
109. Sluimer JC, Daemen MJ (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 218:7-29
110. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD et al (1992) A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 85:391-405
111. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:2462-2478
112. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355-1374
113. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimbürger O, Barany P, Alvestrand A, Nordfors L, Qureshi AR, Ekström TJ, Schalling M (2007) Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med 261:488-499
114. Sundström J, Vasan RS (2006) Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events. Curr Opin Lipidol 17:45-53
115. Tang BL (2001) ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 33:33-44
116. Taylor AJ, Burke AP, O'Malley PG, Farb A, Malcom GT, Smialek J, Virmani R (2000) A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 101:1243-1248
117. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D'Agostino RB Sr, Lipinska I, Keaney JF Jr, Benjamin EJ, O'Donnell CJ (2007) Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 99:1598-1602
118. Tomasik A, Jacheć W, Skrzep-Poloczek B, Widera-Romuk E, Wodniecki J, Wojciechowska C (2003) Circulating electronegatively charged low-density lipoprotein in patients with angiographically documented coronary artery disease. Scand J Clin Lab Invest 63:259-265
119. Tomkin GH, Owens D (2001) Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev 17:27-43
120. Turunen MP, Aavik E, Ylä-Herttuala S (2009) Epigenetics and atherosclerosis. Biochim Biophys Acta 1790:886-891
121. van Goor H, Melenhorst WB, Turner AJ, Holgate ST (2009) Adamalysins in biology and disease. J Pathol 219:277-286
122. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2012:62-1275
123. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscl Thromb Vasc Biol 25:205420-205461
124. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47:C13-C18
125. Weber C, Zernecke A, Libby P (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8:802-815
126. Wight TN (2005) The ADAMTS proteases, extracellular matrix, and vascular disease: waking the sleeping giant(s)! Arterioscler Thromb Vasc Biol 25:12-14
127. Williams H, Johnson JL, Jackson CL, White SJ, George SJ (2010) MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovasc Res 87:137-146
128. Zernecke A, Weber C (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100(2):93-100
129. Zernecke A, Weber C (2010) Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 86:192-201
130. Zernecke A, Shagdarsuren E, Weber C (2008) Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 28:1897-1908